Izalontamab brengitecan: Data readout from P1 LUNG-101 trial (NCT05983432) for 1L NSCLC and advanced solid tumors in H2 2025 (Bristol-Myers Squibb) - Apr 24, 2025 - Q1 2025 Results: Data readout from P1/2 trial (NCT06618287) for advanced solid tumors in 2026
P1 data • P1/2 data • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor
|